Nuvation Bio NUVB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $143.05M+127% | $62.9M+135% | $26.75M+86.3% | $14.36M+31.0% | $10.96M+39.2% | ||
| $125.55M+9.1% | $115.11M+4.5% | $110.11M+1.0% | $108.99M-1.7% | $110.88M+11.9% | ||
| $154.48M+1.9% | $151.56M+10.3% | $137.37M+14.9% | $119.6M+23.0% | $97.27M+40.5% | ||
| $714K-1.1% | $722K-7.8% | $783K-7.8% | $849K-7.1% | $914K-6.4% | ||
| $295.32M+6.2% | $278.06M+8.3% | $256.65M+7.9% | $237.76M-63.0% | $642.39M+7.0% | ||
| $295.32M+6.2% | $278.06M+8.3% | $256.65M+7.9% | $237.76M-63.0% | $642.39M+7.0% | ||
| $20.34M+48.6% | $13.68M+92.8% | $7.1M+938% | $684K+73.2% | $395K+15.8% | ||
| —— | —— | $15.49M-28.7% | $21.74M-13.2% | $25.05M+1.5% | ||
| -$145.99M+28.7% | -$204.63M+5.9% | -$217.48M-7.2% | -$202.9M+66.5% | -$606.38M-6.8% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| -$145.99M+28.7% | -$204.63M+5.9% | -$217.48M-7.2% | -$202.9M+66.5% | -$606.38M-6.8% | ||
| -102.1%+223pp | -325.3%+488pp | -813.1%+600pp | -1,413.4%+4,121pp | -5,534.2%+1,680pp | ||
| -$0.42+30.0% | -$0.60-22.4% | -$0.49-2.1% | -$0.48+78.2% | -$2.20-4.3% | ||
| 1.4B+2.9% | 1.4B+5.6% | 1.3B+5.6% | 1.2B+8.5% | 1.1B+11.9% | ||
| 1.4B+0.6% | 1.4B+5.6% | 1.3B+5.6% | 1.2B+8.5% | 1.1B+11.9% | ||
| —— | —— | —— | —— | $7.4M+4.6% | ||
| -$148.22M+27.8% | -$205.39M+6.2% | -$219M-8.4% | -$201.96M+66.6% | -$604.67M-6.5% | ||
| $12K-98.4% | $741K+134% | -$2.16M-395% | $732K+2.8% | $712K+591% | ||
| —— | —— | —— | —— | -$3.61M-153% | ||
| $7.72M+74.4% | $4.42M— | —— | —— | —— | ||
| $202.03M-0.2% | $202.54M— | —— | —— | —— | ||
| —— | —— | —— | $189.95M+12.2% | $169.34M+38.0% | ||
| -$125.73M+27.5% | -$173.43M+8.7% | -$190M-13.0% | -$168.19M-6.9% | -$157.34M-20.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.25M+35.5% | $1.66M+55.1% | $1.07M+123% | $481K+541% | ||
| $143.05M+127% | $62.9M+135% | $26.75M+86.3% | $14.36M+31.0% | $10.96M+39.2% | ||
| —— | —— | —— | —— | $0— | ||
| $2.23M+48.9% | $1.5M+335% | -$637K-206% | -$208K+79.2% | -$1M-86.6% | ||
| -$148.21M+29.9% | -$211.33M+8.7% | -$231.55M-3.6% | -$223.59M+64.5% | -$630.5M-6.5% | ||
| -103.6%+232pp | -336%+530pp | -865.7%+692pp | -1,557.6%+4,197pp | -5,754.3%+1,764pp | ||
| -$150.18M+29.5% | -$213.06M+8.5% | -$232.97M-3.7% | -$224.64M+64.4% | -$631.43M-6.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Nuvation Bio's profit margins?
- Gross margin is 54.3% and operating margin is -105.0%, with a -102.1% net margin.
- Where does Nuvation Bio's income statement data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.